Exposure to air pollutants (PM2.5 and PM10) is associated with an increased risk of persistent long-COVID symptoms, partly due to its impact on the severity
Research shows a dramatic 62% decrease in cervical cancer mortality in U.S. women under 25, attributed to HPV vaccination and enhanced screening efforts.
Through an analysis of tweets (now rebranded X) relating to obesity published between April 2019 and December 2022, a study conducted by the Geneva University
Announcing a new article publication for Zoonoses journal. Zoonotic transmission of severe acute respiratory coronavirus 2 (SARS-CoV-2) has been found to result in infections in
One in five young Spaniards spends more than two hours a day on TikTok and exceeds the recommended limits for the use of social media,
A new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a study
In recent years, the evolution of biologic therapies for severe asthma has paralleled advancements in other chronic conditions such as rheumatoid arthritis and psoriasis, where
Tevimbra is a monoclonal antibody that targets the PD-1 receptor. Credit: rawf8 via Shutterstock. The European Commission has approved BeiGene’s PD-1 inhibitor Tevimbra (tislelizumab) in
In recent years, GLP-1 receptor (GLP-1R) products have gained immense popularity. Currently, four innovative GLP-1Rs are approved worldwide for obesity, all of which are injectables.
Outlook’s Lytenava is a recombinant monoclonal antibody that binds and blocks vascular endothelial growth factor (VEGF) thereby reducing endothelial cell proliferation, vascular leakage, and new